Smoking, Stress & Allopregnanolone Response

Completed

Conditions studied: Smoking Cessation

In brief

This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.

Key facts

Study ID

NCT02087800

Run by

University of Minnesota

People needed

43

Starts

2014-04-01

Expected to finish

2015-08-01

Last updated by the study team

2015-11-30

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female between the ages of 18-40 years old
• Stable physical/mental health,
• Self-report of regular menstrual cycles,
• Self-report of either smoking either current or never smoking,
• English fluency,
• Ability to provide informed consent

You may not qualify if…

• Self-report of current use of illicit drugs, other tobacco products, nicotine, or smoking cessation medications,
• Current or recent pregnancy or breastfeeding,
• Current or recent use of exogenous hormones (including birth control pills),
• Current or recent use of psychotropic medications.

Where it is running

• University of Minnesota Tobacco Research Program — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.